TRISTEL
 
Notifications
Clear all

TSTL - TRISTEL - Share Chat

Price: Market Cap.: (Ā£m)

Tristel Plc (AIM: TSTL) is a UK-listed manufacturer of infection prevention products, primarily high-level disinfectants and sporicides. Utilising its proprietary chlorine dioxide chemistry, the company focuses on healthcare settings, including the reprocessing of medical devices, as well as veterinary and pharmaceutical compounding sectors. Tristel’s solutions are vital for preventing hospital-acquired infections and ensuring patient safety. The business model is largely recurring, driven by consumable sales of its disinfectants and related accessories. With a significant international presence, the company continues to expand its global reach, capitalising on increasing demands for stringent infection control standards across healthcare industries.

Posts: 1675
Topic starter
(@mrmultibagger)
Member
Joined: 3 years ago

Chat about TRISTEL


1 Reply
Posts: 1675
Topic starter
(@mrmultibagger)
Member
Joined: 3 years ago

TRISTEL (TSTL): What are your thoughts on its trajectory?

The recent acquisition of ASP's WaM business by Tristel looks like a significant move. How do you see this impacting their growth prospects and market share in the infection prevention sector? Is TSTL undervalued, or fairly priced given current performance? Always interested to hear fellow investors' perspectives.


Reply

Scroll to Top